Advertisement
News
Advertisement

New Peripheral Vascular Device Market Research Data Covering Multiple Geographies Released by Millennium Research Group

Mon, 11/15/2010 - 7:35am
Bio-Medicine.Org

TORONTO, Nov. 15, 2010 /PRNewswire/ -- Millennium Research Group (MRG), the global authority on medical technology market intelligence, has released its latest peripheral vascular research data for multiple geographies, including the US, Canada, Europe, Asia Pacific, and Latin America.

MRG's peripheral vascular reports cover minimally invasive and surgical treatments for peripheral artery disease, including stenting, percutaneous transluminal balloon angioplasty, and synthetic surgical bypass. The reports provide a breakdown of different interventions performed in the major vessel beds including carotid, renal, iliac, femoropopliteal, infrapopliteal, and arteriovenous access treatments. Some regions also include a review of newer technologies such as peripheral drug-eluting stents and drug-coated balloons, in addition to an analysis of the booming abdominal and thoracic aortic stent graft markets.

"Reports also provide a detailed analysis of the competitive landscape and include market shares and qualitative discussions of the leading competitors in each market segment," says Stephanie LaBelle, Manager of the Cardiovascular division at MRG.  "Based on primary research with industry professionals, MRG uses proprietary forecasting models to provide an in-depth examination of current and future trends in procedure volumes, unit sales, average selling prices, and market values over a 7-year period."

MRG's latest peripheral vascular reports include US Markets for Peripheral Vascular Devices 2011, European Markets for Peripheral Vascular Devices 2011, Asia Pacific Markets for Peripheral Vascular Devices 2011, Canadian Markets for Peripheral Vascular Devices 2011, and Latin American Markets for Peripheral Vascular Devices 2011.  Please contact Amy Krohn at 416-364-7776 ext. 101 or akrohn@mrg.net fo

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading